386847004: Mirtazapine (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\...

\Substance with adrenergic receptor antagonist mechanism of action (substance)\Alpha adrenergic receptor antagonist\Mirtazapine (substance)

\Histamine receptor antagonist\Histamine H1 receptor antagonist\Mirtazapine (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Alpha adrenergic receptor antagonist\Mirtazapine (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Central nervous system agent (substance)\Psychoactive substance (substance)\Psychotropic agent (substance)\Antidepressant (substance)\Tetracyclic antidepressant (substance)\Mirtazapine (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\...

\Substance with tetracyclic structure (substance)\Tetracyclic antidepressant (substance)\Mirtazapine (substance)

\Benzazepine (substance)\Mirtazapine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Mirtazapine (substance)	Is a	Tetracyclic antidepressant (substance)	true	Inferred relationship	Some
Mirtazapine (substance)	Is a	Histamine H1 receptor antagonist	true	Inferred relationship	Some
Mirtazapine (substance)	Is a	Substance with adrenergic receptor antagonist mechanism of action (substance)	false	Inferred relationship	Some
Mirtazapine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha adrenergic receptor antagonist	true	Inferred relationship	Some
Mirtazapine (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Histamine H1 receptor antagonist (disposition)	true	Inferred relationship	Some
Mirtazapine (substance)	Is a	Benzazepine (substance)	true	Inferred relationship	Some
Mirtazapine (substance)	Is a	Alpha adrenergic receptor antagonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing mirtazapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine measurement	Component	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Mirtazapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Mirtazapine 15 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Mirtazapine 45 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Oral form mirtazapine tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Oral form mirtazapine disintegrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Mirtazapine 45mg disintegrating tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Mirtazapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Adverse reaction to mirtazapine	Causative agent (attribute)	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 45 mg orodispersible tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some
Mirtazapine 30 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 30 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 15 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 15 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 45 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 45 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 7.5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 7.5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 15 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 30 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 7.5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 45 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Product containing only mirtazapine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Product containing only mirtazapine in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 15 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 15 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Product containing precisely mirtazapine 30 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 45 mg orodispersible tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Mirtazapine (substance)	Inferred relationship	Some	1
Mirtazapine 45 mg orodispersible tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Product containing mirtazapine in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirtazapine (substance)	Inferred relationship	Some	1
Product containing only mirtazapine in oromucosal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Mirtazapine (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1461025015	Mirtazapine (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
1480962018	Mirtazapine	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
55551000195112	mirtazapina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
825891000172113	mirtazapine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
70591000195112	Mirtazapin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module